ALK-positive bone cancer

Clinical trials for ALK-positive bone cancer explained in plain language.

Never miss a new study

Get alerted when new ALK-positive bone cancer trials appear

Sign up with your email to follow new studies for ALK-positive bone cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New hope for rare bone cancer: targeted drugs enter early trial

Disease control Not yet recruiting

This early-phase trial will test two targeted drugs, crizotinib and alectinib, in 10 adults with a rare form of bone cancer that has a specific ALK gene change. Participants must have already tried standard treatments or have no standard options left. The goal is to see if these …

Matched conditions: ALK-POSITIVE BONE CANCER

Phase 1/2 • Sponsor: China Medical University Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC

ALK-positive bone cancer

Get alerted when new ALK-positive bone cancer trials appear

New hope for rare bone cancer: targeted drugs enter early trial